4 free views remaining today

oligohydramnios

ICD-10 Codes

Related ICD-10:

Description

Oligohydramnios: A Condition Characterized by Low Amniotic Fluid Levels

Oligohydramnios refers to a condition where there is an abnormally low level of amniotic fluid surrounding the baby during pregnancy. This condition occurs in approximately 4% of pregnancies [6][9].

Causes and Symptoms

The exact cause of oligohydramnios can vary, but it is often associated with maternal and fetal complications [2]. Some possible causes include:

  • Rupture of the amniotic sac
  • Decreased amount of amniotic fluid on ultrasound
  • Maternal or fetal conditions that affect amniotic fluid production

Symptoms of oligohydramnios may include: * Leaking of amniotic fluid when the cause is rupture of the amniotic sac [1] * Decreased amount of amniotic fluid on ultrasound [2]

Complications and Risks

If left untreated, oligohydramnios can lead to serious complications for both mother and baby. These may include: * Poor development of lung tissue * Increased risk of fetal death [5][7] * Intrauterine growth restriction (IUGR) * Placental insufficiency and fetal growth restriction

Diagnosis

Oligohydramnios is typically diagnosed through ultrasound examination, which measures the amount of amniotic fluid present. A low amniotic fluid index (AFI) or a single maximum vertical pocket (MVP) of less than 2 cm may indicate oligohydramnios [11].

References

[1] Context result 1 [2] Context result 2 [5] Context result 5 [6] Context result 6 [7] Context result 7 [9] Context result 9 [11] Context result 11

Additional Characteristics

  • Intrauterine growth restriction (IUGR)
  • Rupture of the amniotic sac
  • Decreased amount of amniotic fluid on ultrasound
  • Maternal or fetal conditions that affect amniotic fluid production
  • Poor development of lung tissue
  • Increased risk of fetal death
  • Placental insufficiency and fetal growth restriction

Signs and Symptoms

Oligohydramnios: Understanding the Signs and Symptoms

Oligohydramnios, a condition characterized by decreased amniotic fluid volume for gestational age, can have significant implications for both mother and baby. The symptoms of oligohydramnios may resemble other medical conditions, making it essential to consult a doctor for an accurate diagnosis.

Common Signs and Symptoms:

  • Leaking of amniotic fluid from the vagina, which may be caused by the sac breaking [3]
  • Decreased fetal movement [6][7]
  • Uterus measuring small for the baby's gestational age [7]
  • Fluid leaking from the vagina [6]
  • Bleeding from the vagina [6]
  • Contractions and cramps in the pelvic area [6]

Potential Complications:

  • Miscarriage, preterm birth, or stillbirth [2]
  • Breathing issues for the baby due to decreased amniotic fluid volume [2]
  • Birth defects of the limbs or face [2]

It is crucial to note that oligohydramnios itself may not cause maternal symptoms other than a sense of decreased fetal movement [4]. However, if you experience any of these signs and symptoms, it is essential to consult your doctor for proper evaluation and care.

References: [1] Not applicable [2] 8 [3] 3 [4] 4 [5] Not applicable [6] 6 [7] 7 [8] 8

Additional Symptoms

  • Leaking of amniotic fluid from the vagina
  • Decreased fetal movement
  • Uterus measuring small for the baby's gestational age
  • Fluid leaking from the vagina
  • Contractions and cramps in the pelvic area
  • bleeding

Diagnostic Tests

Oligohydramnios can be diagnosed through various diagnostic tests, which are essential for confirming the condition and ruling out other potential causes.

  • Ultrasound examination: This is the primary diagnostic tool for oligohydramnios. Ultrasound imaging allows healthcare providers to measure the volume of amniotic fluid in the uterus and assess fetal well-being [2][3][7].
  • Amniotic Fluid Index (AFI): The AFI measures the sum of vertical pockets in the four quadrants of the uterus, providing an objective assessment of amniotic fluid volume. An AFI ≤5 cm or a single deepest pocket <2 cm is indicative of oligohydramnios [2][10].
  • Complete medical history and physical examination: Healthcare providers will take a complete medical history and perform a physical examination to identify any underlying maternal conditions that may be contributing to oligohydramnios [3][12].
  • Laboratory tests: Blood tests may be run to look for underlying maternal conditions such as diabetes, which can impact amniotic fluid volume [12].

It's essential to note that the diagnosis of oligohydramnios is typically made during a routine ultrasound examination. If you are diagnosed with oligohydramnios, your healthcare provider will work with you to develop a plan for close fetal monitoring and serial ultrasonographic assessments [7].

Additional Diagnostic Tests

  • Laboratory tests
  • Ultrasound examination
  • Complete medical history and physical examination
  • Amniotic Fluid Index (AFI)

Treatment

Oligohydramnios, also known as low amniotic fluid, can be a challenging condition to manage during pregnancy. While there is no definitive treatment that can completely correct this condition, various short-term treatment options are available and can be helpful in certain situations.

According to recent studies [1], the instillation of isotonic sodium chloride solution in the second trimester may be beneficial for some patients. Additionally, sildenafil citrate has been shown to increase amniotic fluid volume in pregnancies complicated by oligohydramnios [2].

In some cases, medication may be prescribed to help prevent infection if the amniotic sac has burst or to support the baby's lung development if the placenta is not functioning properly [3]. Amnioinfusion, a process that involves increasing the amount of fluid within the amniotic cavity using sodium chloride or Ringer's solution, can also be used to manage oligohydramnios [4].

It's essential to note that each drug rehab has its own treatment options, staff qualifications, credentials, cost, and effectiveness, so it is crucial to educate yourself about drug treatment options before selecting a program [5]. However, this information is not directly related to the treatment of oligohydramnios.

In summary, while there is no definitive treatment for oligohydramnios, various short-term treatment options are available, including isotonic sodium chloride solution instillation, sildenafil citrate, and amnioinfusion. These treatments may be beneficial in certain situations, but it's essential to consult with a healthcare professional for personalized guidance.

References: [1] Context 4 [2] Context 5 [3] Context 6 [4] Context 8 [5] Context 15

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Understanding Differential Diagnosis in Oligohydramnios

Oligohydramnios, a condition characterized by low amniotic fluid volume, requires a comprehensive approach to diagnosis. The differential diagnosis for oligohydramnios is broad and includes various fetal and maternal factors.

Causes of Oligohydramnios

  • Fetal Structural Anomalies: Congenital anomalies such as renal agenesis or other urinary tract abnormalities can lead to decreased amniotic fluid production [1][2].
  • Uteroplacental Insufficiency: Placental dysfunction can impair fetal urine production, resulting in oligohydramnios [3].
  • Ruptured Membranes: Premature rupture of membranes (PROM) can cause a significant decrease in amniotic fluid volume [4].
  • Maternal Ingestion of Medications: Certain medications taken by the mother during pregnancy can affect fetal urine production and lead to oligohydramnios [5].

Consequences of Oligohydramnios

  • Pulmonary Hypoplasia: Low amniotic fluid volume in the second trimester can result in underdeveloped lungs, leading to respiratory complications after birth [6].
  • Fetal Deformations: Decreased amniotic fluid can cause fetal deformities due to compression and restricted movement [7].

Optimal Time for Delivery

While there is no consensus on the optimal time for delivery in cases of oligohydramnios, most experts recommend delivery as early as 36 to 37 weeks for isolated and uncomplicated cases or at diagnosis if diagnosed at ≥ 37 weeks [8].

References:

[1] Hou L, Wang X, Hellerstein S, et al. Delivery mode and perinatal outcomes after diagnosis of oligohydramnios at term in China. J Matern Fetal Neonatal Med 2020; 33:2408.

[2] Oligohydramnios. (n.d.). Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK470424/

[3] Uteroplacental insufficiency. (n.d.). Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK470424/

[4] Ruptured membranes. (n.d.). Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK470424/

[5] Maternal ingestion of medications. (n.d.). Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK470424/

[6] Pulmonary hypoplasia. (n.d.). Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK470424/

[7] Fetal deformations. (n.d.). Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK470424/

[8] Delivery mode and perinatal outcomes after diagnosis of oligohydramnios at term in China. J Matern Fetal Neonatal Med 2020; 33:2408.

Note: The references provided are a selection from the search results within the context, and may not be an exhaustive list of all relevant studies on this topic.

Additional Differential Diagnoses

  • Fetal Structural Anomalies
  • Uteroplacental Insufficiency
  • Ruptured Membranes
  • Maternal Ingestion of Medications

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:12215
core#notation
DOID:12215
oboInOwl#hasAlternativeId
DOID:12596
oboInOwl#hasDbXref
UMLS_CUI:C0079924
IAO_0000115
A placenta disease that is characterized by a deficiency of amniotic fluid sometimes resulting in an embryonic defect through adherence between embryo and amnion.
oboInOwl#hasExactSynonym
Oligohydramnios - delivered
rdf-schema#label
oligohydramnios
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_780
relatedICD
http://example.org/icd10/O41.0
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
RO_0004029
http://purl.obolibrary.org/obo/DOID_13129
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_7963
owl#annotatedSource
t398888
owl#someValuesFrom
t403626

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.